［1］Capitanio U，Montorsi F.Renal cancer［J］.Lancet，2016，387(10021)：894-906.
［2］Ferlay J，Shin HR，Bray F，et al.Estimates of worldwide burden of cancer in 2008：GLOBOCAN 2008［J］.Int J Cancer，2010，127(12)：2893-2917.
［3］Zarrabi K，Wu S.Current and emerging therapeutic targets for metastatic renal cell carcinoma［J］.Curr Oncol Rep，2018，20(5)：41.
［4］Barata PC，Rini BI.Treatment of renal cell carcinoma：Current status and future directions［J］.CA Cancer J Clin，2017，67(6)：507-524.
［5］Guttman M，Rinn JL.Modular regulatory principles of large non-coding RNAs［J］.Nature，2012，482(7385)：339-346.
［6］Rossi MN，Antonangeli F.LncRNAs：New players in apoptosis control［J］.Int J Cell Biol，2014（2014）：473857.
［7］Khorkova O，Hsiao J，Wahlestedt C.Basic biology and therapeutic implications of lncRNA［J］.Adv Drug Deliv Rev，2015(87)：15-24.
［8］Song S，Wu Z，Wang C，et al.RCCRT1 is correlated with prognosis and promotes cell migration and invasion in renal cell carcinoma［J］.Urology，2014，84(3)：730-731.
［9］Zhang HM，Yang FQ，Yan Y，et al.High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma［J］.Int J Clin Exp Pathol，2014，7(9)：5801-5809.
［10］Wang L，Cai Y，Zhao X，et al.Down-regulated long non-coding RNA H19 inhibits carcinogenesis of renal cell carcinoma［J］.Neoplasma，2015，62(3)：412-418.
［11］Hirata H，Hinoda Y，Shahryari V，et al.Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205［J］.Cancer Res，2015，75(7)：1322-1331.
［12］Zhang HM，Yang FQ，Chen SJ，et al.Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma［J］.Tumour Biol，2015，36(4)：2947-2955.
［13］Yao J，Chen Y，Wang Y，et al.Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas［J］.Int J Clin Exp Pathol，2014，7(6)：2758-2767.
［14］Xue S，Li QW，Che JP，et al.Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma［J］.Int J Clin Exp Pathol，2015，8(4)：3765-3774.
［15］Ellinger J，Alam J，Rothenburg J，et al.The long non-coding RNA lnc-ZNF180-2 is a prognostic biomarker in patients with clear cell renal cell carcinoma［J］.Am J Cancer Res，2015，5(9)：2799-2807.
［16］Liu H，Chen P，Jiang C，et al.Screening for the key lncRNA targets associated with metastasis of renal clear cell carcinoma［J］.Medicine (Baltimore)，2016，95(2)：e2507.
［17］Sakurai K，Reon BJ，Anaya J，et al.The incRNA DRAIC/PCAT29 locus constitutes a tumor-suppressive nexus［J］.Mol Cancer Res，2015，13(5)：828-838.
［18］Xu S，Wang P，You Z，et al.The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors［J］.Oncotarget，2016，7(15)：20704-20717.
［19］Yan Y，Fan Q，Wang L，et al.LncRNA Snhg1，a non-degradable sponge for miR-338，promotes expression of proto-oncogene CST3 in primary esophageal cancer cells［J］.Oncotarget，2017，8(22)：35750-35760.
［20］Li J，Zhang Z，Xiong L，et al.SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer［J］.Biochem Biophys Res Commun，2017，487(1)：146-152.
［21］Wang Q，Li Q，Zhou P，et al.Upregulation of the long non-coding RNA SNHG1 predicts poor prognosis，promotes cell proliferation and invasion，and reduces apoptosis in glioma［J］.Biomed Pharmacother，2017(91)：906-911.
［22］Cui Y，Zhang F，Zhu C，et al.Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/beta-catenin signaling pathway［J］.Oncotarget，2017，8(11)：17785-17794.
［23］Zhao S，Wang Y，Luo M，et al.Long noncoding RNA small nucleolar rna host gene 1 (SNHG1) promotes renal cell carcinoma progression and metastasis by negatively regulating miR-137［J］.Med Sci Monit，2018(24)：3824-3831.
［24］Huang C，Liu S，Wang H，et al.LncRNA PVT1 overexpression is a poor prognostic biomarker and regulates migration and invasion in small cell lung cancer［J］.Am J Transl Res，2016，8(11)：5025-5034.
［25］Liu HT，Fang L，Cheng YX，et al.LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a［J］.Cancer Med，2016，5(12)：3512-3519.
［26］Posa I，Carvalho S，Tavares J，et al.A pan-cancer analysis of MYC-PVT1 reveals CNV-unmediated deregulation and poor prognosis in renal carcinoma［J］.Oncotarget，2016，7(30)：47033-47041.
［27］Bao X，Duan J，Yan Y，et al.Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma［J］.Cancer Biomark，2017，21(1)：55-63.
［28］Zang W，Wang T，Wang Y，et al.Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma［J］.Oncotarget，2016，7(15)：19960-19974.
［29］Liu G，Zhao X，Zhou J，et al.LncRNA TP73-AS1 promotes cell proliferation and inhibits cell apoptosis in clear cell renal cell carcinoma through repressing KISS1 expression and inactivation of PI3K/Akt/mTOR signaling pathway［J］.Cell Physiol Biochem，2018，48(1)：371-384.
［30］Wang KC，Yang YW，Liu B，et al.A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression［J］.Nature，2011，472(7341)：120-124.
［31］Cheng Y，Jutooru I，Chadalapaka G，et al.The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation，survival and migration［J］.Oncotarget，2015，6(13)：10840-10852.
［32］Sun Y，Zeng C，Gan S，et al.LncRNA HOTTIP-mediated HOXA11 expression promotes cell growth，migration and inhibits cell apoptosis in breast cancer［J］.Int J Mol Sci，2018，19(2)：472.
［33］Peng F，Shi X，Meng Y，et al.Long non-coding RNA HOTTIP is upregulated in renal cell carcinoma and regulates cell growth and apoptosis by epigenetically silencing of LATS2［J］.Biomed Pharmacother，2018(105)：1133-1140.
［34］Mantena SK，Sharma SD，Katiyar SK.Berberine，a natural product，induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells［J］.Mol Cancer Ther，2006，5(2)：296-308.
［35］Young TL，Matsuda T，Cepko CL.The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina［J］.Curr Biol，2005，15(6)：501-512.
［36］Zhang Q，Geng PL，Yin P，et al.Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis［J］.Asian Pac J Cancer Prev，2013，14(4)：2311-2315.
［37］Han Y，Liu Y，Gui Y，et al.Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder［J］.J Surg Oncol，2013，107(5)：555-559.
［38］Wang PQ，Wu YX，Zhong XD，et al.Prognostic significance of overexpressed long non-coding RNA TUG1 in patients with clear cell renal cell carcinoma［J］.Eur Rev Med Pharmacol Sci，2017，21(1)：82-86.
［39］Zhang M，Lu W，Huang Y，et al.Downregulation of the long noncoding RNA TUG1 inhibits the proliferation，migration，invasion and promotes apoptosis of renal cell carcinoma［J］.J Mol Histol，2016，47(4)：421-428.
［40］Wang XS，Zhang Z，Wang HC，et al.Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma［J］.Clin Cancer Res，2006，12(16)：4851-4858.
［41］Xue M，Chen W，Li X.Urothelial cancer associated 1：A long noncoding RNA with a crucial role in cancer［J］.J Cancer Res Clin Oncol，2016，142(7)：1407-1419.
［42］Wang F，Ying HQ，He BS，et al.Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway［J］.Oncotarget，2015，6(10)：7899-7917.
［43］Li Y，Wang T，Li Y，et al.Identification of long-non coding RNA UCA1 as an oncogene in renal cell carcinoma［J］.Mol Med Rep，2016，13(4)：3326-3334.
［44］Lu Y，Liu WG，Lu JH，et al.LncRNA UCA1 promotes renal cell carcinoma proliferation through epigenetically repressing p21 expression and negatively regulating miR-495［J］.Tumour Biol，2017，39(5)：1393388032.
［45］Liu Q，Li Y，Lv W，et al.UCA1 promotes cell proliferation and invasion and inhibits apoptosis through regulation of the miR129-SOX4 pathway in renal cell carcinoma［J］.Onco Targets Ther，2018(11)：2475-2487.
［46］Flockhart RJ，Webster DE，Qu K，et al.BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration［J］.Genome Res，2012，22(6)：1006-1014.
［47］He A，Liu Y，Chen Z，et al.Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer［J］.J Exp Clin Cancer Res，2016，35(1)：125.
［48］Shi Y，Liu Y，Wang J，et al.Downregulated long noncoding RNA BANCR promotes the proliferation of colorectal cancer cells via downregualtion of p21 expression［J］.PLoS One，2015，10(4)：e122679.
［49］Wang D，Wang D，Wang N，et al.Long non-coding RNA BANCR promotes endometrial cancer cell proliferation and invasion by regulating MMP2 and MMP1 via ERK/MAPK signaling pathway［J］.Cell Physiol Biochem，2016，40(3-4)：644-656.
［50］Wang LS，Chen SJ，Zhang JF，et al.Anti-proliferative potential of Glucosamine in renal cancer cells via inducing cell cycle arrest at G0/G1 phase［J］.BMC Urol，2017，17(1)：38.
［51］Xue S，Jiang SQ，Li QW，et al.Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma［J］.BMC Urol，2018，18(1)：79.
［52］Li JK，Chen C，Liu JY，et al.Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling［J］.Mol Cancer，2017，16(1)：111.
［53］Liu T，Sui J，Zhang Y，et al.Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma［J］.Oncol Rep，2018，40(3)：1503-1514.
［54］Zuo S，Wang L，Wen Y，et al.Identification of a universal 6-lncRNA prognostic signature for three pathologic subtypes of renal cell carcinoma［J］.J Cell Biochem，2019(120)：7375-7385.
［55］Yin H，Wang X，Zhang X，et al.Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma［J］.Cancer Sci，2018，109(10)：3336-3349.
［56］Heward JA，Lindsay MA.Long non-coding RNAs in the regulation of the immune response［J］.Trends Immunol，2014，35(9)：408-419.
［57］Khadirnaikar S，Kumar P，Pandi SN，et al.Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma［J］.Mol Carcinog，2019，58(4)：544-553.
［58］Treffers LW，Hiemstra IH，Kuijpers TW，et al.Neutrophils in cancer［J］.Immunol Rev，2016，273(1)：312-328.
［59］Wikberg ML，Ling A，Li X，et al.Neutrophil infiltration is a favorable prognostic factor in early stages of colon cancer［J］.Hum Pathol，2017(68)：193-202.
［60］Kondkar AA，Abu-Amero KK.Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases［J］.Biomed Res Int，2015(2015)：821823.
［61］Rossi MN，Antonangeli F.LncRNAs：New players in apoptosis control［J］.Int J Cell Biol，2014(2014)：473857.